FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection
- PMID: 36944608
- PMCID: PMC10028767
- DOI: 10.1038/s41392-023-01390-y
FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment on
-
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.Nature. 2023 Mar;615(7950):134-142. doi: 10.1038/s41586-022-05594-0. Epub 2022 Dec 5. Nature. 2023. PMID: 36470304 Free PMC article.
References
-
- Martens, K., Vanhulle, E., Viskens, A., Hellings, P. W. & Vermeire, K. Fluticasone propionate suppresses the SARS-CoV-2 induced increase in respiratory epithelial permeability in vitro. Rhinology (2022). 10.4193/Rhin22.223. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
